https://www.marketscreener.com/quote/stock/MERCK-CO-INC-13611/news/European-Commission-Approves-Merck-s-KEYTRUDA-pembrolizumab-Plus-Chemotherapy-as-Treatment-for-Ce-36760241/?utm_source=telegram&utm_medium=social&utm_campaign=share